Subscribe
shutterstock_749771347_scotyard
Scotyard / Shutterstock.com
9 September 2019AmericasSarah Morgan

Pharma industry challenges Canada’s drug pricing plan

Innovative Medicines Canada (IMC), an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Trump confounds big pharma with low-cost drugs import plan
1 August 2019   In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.
Big Pharma
Canadian generics plan could deter big pharma: report
17 April 2019   Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.
Americas
Canada's drug pricing plan prompts backlash
26 October 2020   The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Trump confounds big pharma with low-cost drugs import plan
1 August 2019   In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.
Big Pharma
Canadian generics plan could deter big pharma: report
17 April 2019   Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.
Americas
Canada's drug pricing plan prompts backlash
26 October 2020   The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

More on this story

Americas
Trump confounds big pharma with low-cost drugs import plan
1 August 2019   In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.
Big Pharma
Canadian generics plan could deter big pharma: report
17 April 2019   Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.
Americas
Canada's drug pricing plan prompts backlash
26 October 2020   The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?